BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8959390)

  • 1. QSAR of P450 oxidation: on the value of comparing kcat and km with kcat/km.
    Gao H; Hansch C
    Drug Metab Rev; 1996 Nov; 28(4):513-26. PubMed ID: 8959390
    [No Abstract]   [Full Text] [Related]  

  • 2. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the reduction of cytochrome b5 with mutations in its membrane-binding domain.
    Wu FF; Vergères G; Waskell L
    Arch Biochem Biophys; 1994 Feb; 308(2):380-6. PubMed ID: 7906503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
    Patten CJ; Koch P
    Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationships of cytochrome P-450.
    Hansch C; Zhang L
    Drug Metab Rev; 1993; 25(1-2):1-48. PubMed ID: 8449144
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.
    Watanabe K; Matsunaga T; Yamamoto I; Yashimura H
    Drug Metab Dispos; 1995 Feb; 23(2):261-5. PubMed ID: 7736922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytochrom P-450. Its value in toxicology. I. Physicochemical and biochemical properties].
    Boudene C; Boisset M
    Ann Biol Clin (Paris); 1975; 33(6):399-410. PubMed ID: 179450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
    Usuki E; Pearce R; Parkinson A; Castagnol N
    Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms.
    Perret A; Pompon D
    Biochemistry; 1998 Aug; 37(33):11412-24. PubMed ID: 9708976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for the differences in lidocaine binding and regioselectivity of oxidation by cytochromes P450 2B1 and 2B2.
    Hanna IH; Roberts ES; Hollenberg PF
    Biochemistry; 1998 Jan; 37(1):311-8. PubMed ID: 9425052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroxide-dependent oxidation of substrates of polysynthetic flavocytochrome 2B4].
    Shumiantseva VV; Avdeenko IuL; Moskvitina TL; Bulko TV; Osipov AN; Archakov AI
    Vopr Med Khim; 1998; 44(4):369-75. PubMed ID: 9845924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
    de Groot MJ; Bijloo GJ; Hansen KT; Vermeulen NP
    Drug Metab Dispos; 1995 Jun; 23(6):667-9. PubMed ID: 7587951
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P450.
    Peng HM; Raner GM; Vaz AD; Coon MJ
    Arch Biochem Biophys; 1995 Apr; 318(2):333-9. PubMed ID: 7733661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interrelationship between the generation of oxygen anion-radicals and the reduction of artificial acceptors and cytochrome P-450 by NADPH-cytochrome c reductase].
    Liakhovich VV; Mishin VM; Pokrovskii AG
    Biokhimiia; 1977 Jul; 42(7):1323-30. PubMed ID: 198028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochromes P450: their active-site structure and mechanism of oxidation.
    Koymans L; Donné-op den Kelder GM; Koppele Te JM; Vermeulen NP
    Drug Metab Rev; 1993; 25(3):325-87. PubMed ID: 8404461
    [No Abstract]   [Full Text] [Related]  

  • 17. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s.
    Asai H; Imaoka S; Kuroki T; Monna T; Funae Y
    J Pharmacol Exp Ther; 1996 May; 277(2):1004-9. PubMed ID: 8627510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of His163 of cytochrome P450 1A2 in catalytic functions associated with cytochrome b5.
    Mayuzumi H; Shimizu T; Sambongi C; Hiroya K; Hatano M
    Arch Biochem Biophys; 1994 May; 310(2):367-72. PubMed ID: 8179321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
    Raner GM; Vaz AD; Coon MJ
    Mol Pharmacol; 1996 Mar; 49(3):515-22. PubMed ID: 8643091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes.
    Meunier B; de Visser SP; Shaik S
    Chem Rev; 2004 Sep; 104(9):3947-80. PubMed ID: 15352783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.